Erythropoietin beta

From Ganfyd

rINN: Erythropoietin beta

Other Names

NeoRecormon^®

Pharmacological Information

Pharmacology Images

Human EPO

Web information on Erythropoietin beta

NHS Evidence on Erythropoietin beta

DrugBank on Erythropoietin beta

Relevant Clinical Literature

Pubmed on Erythropoietin beta

RCT with Erythropoietin beta

Systematic reviews of Erythropoietin beta

Erythropoietin beta in N Eng J Med, Lancet, JAMA, BMJ

Erythropoietin beta in Cochrane Collaboration

TRIP Database on Erythropoietin beta

Google Scholar on Erythropoietin beta

Bandolier on Erythropoietin beta

UK Guidance

SNOMED search

Nice Guidance on Erythropoietin beta

BNF-registration required
BNF for children-registration required

UK directory of medicines

UK Medicine Guide (eg pictures of capsules)

Centre for Reviews and Dissemination databases -DARE & NHS EED (evaluates reliability of research)

Prodigy Guidance on Erythropoietin beta

Regulatory Literature

UK SPCs of medicines with marketing authorisation

EMEA search

FDA search

Other Literature

PubChem on Erythropoietin beta

CTD (Comparative Toxicogenomics Database) link

ChemIndustry.com link

Protein Structural Information

Biological Information (GenomeNet)

Protein Knowledgebase (UniProtKB)

Please read pharmacological data limitations

Other Wikis

Medpedia on Erythropoietin beta (Less technical, good quality control)

Wikipedia on Erythropoietin beta (Less technical, ? quality control)

Introduction

A recombinant erythropoietin analogue.

Clinical Use

Indications

• Prevention anaemia of prematurity in neonates
• Anaemia in chronic renal failure
• Anaemia induced by chemotharapy

Administration

IV

Clinical Issues

Contra-indications

• Pure red cell aplasia on any erythropoeitin
• Uncontrolled hypertension

Cautions and Interactions

Side effects

• Oedema
• Red cell aplasia

Special advice

Pharmacology